AAAAAA

   
Results: 1-25 | 26-50 | 51-53
Results: 26-50/53
DISCUSSION - LUNG-CANCER
Authors: CARNEY DN BUNN PA BELANI CP",GIACCONE,"SHEPHERD FA CALVERT AH COMIS RL SPLINTER TAW ETTINGER DS JOHNSON DH LANGER CJ GRECO FA HAINSWORTH JD BONOMI P CURRAN WJ CHOY H GLANTZ MJ
Citation: Dn. Carney et al., DISCUSSION - LUNG-CANCER, Seminars in oncology, 23(6), 1996, pp. 140-147
ETOPOSIDE PHOSPHATE INFUSION WITH THERAPEUTIC DRUG-MONITORING IN COMBINATION WITH CARBOPLATIN DOSED BY AREA-UNDER-THE-CURVE - A CANCER-RESEARCH CAMPAIGN PHASE I II COMMITTEE STUDY/
Authors: PORTER D BODDY A THOMAS H LIND M NEWELL D CALVERT AH ROBSON L BRAMPTON M ABRAHAMSEN D WINOGRAD B
Citation: D. Porter et al., ETOPOSIDE PHOSPHATE INFUSION WITH THERAPEUTIC DRUG-MONITORING IN COMBINATION WITH CARBOPLATIN DOSED BY AREA-UNDER-THE-CURVE - A CANCER-RESEARCH CAMPAIGN PHASE I II COMMITTEE STUDY/, Seminars in oncology, 23(6), 1996, pp. 34-44
BIOEQUIVALENCE ASSESSMENT OF ETOPOSIDE PHOSPHATE AND ETOPOSIDE USING PHARMACODYNAMIC AND TRADITIONAL PHARMACOKINETIC PARAMETERS
Authors: MUMMANENI V KAUL S IGWEMEZIE LN NEWELL DR PORTER D THOMAS H CALVERT AH WINOGRAD B BARBHAIYA RH
Citation: V. Mummaneni et al., BIOEQUIVALENCE ASSESSMENT OF ETOPOSIDE PHOSPHATE AND ETOPOSIDE USING PHARMACODYNAMIC AND TRADITIONAL PHARMACOKINETIC PARAMETERS, Journal of pharmacokinetics and biopharmaceutics, 24(4), 1996, pp. 313-325
THE RELATIONSHIP BETWEEN TUMOR GLUTATHIONE CONCENTRATION, GLUTATHIONE-S-TRANSFERASE ISOENZYME EXPRESSION AND RESPONSE TO SINGLE-AGENT CARBOPLATIN IN EPITHELIAL OVARIAN-CANCER PATIENTS
Authors: GHAZALASWAD S HOGARTH L HALL AG GEORGE M SINHA DP LIND M CALVERT AH SUNTER JP NEWELL DR
Citation: S. Ghazalaswad et al., THE RELATIONSHIP BETWEEN TUMOR GLUTATHIONE CONCENTRATION, GLUTATHIONE-S-TRANSFERASE ISOENZYME EXPRESSION AND RESPONSE TO SINGLE-AGENT CARBOPLATIN IN EPITHELIAL OVARIAN-CANCER PATIENTS, British Journal of Cancer, 74(3), 1996, pp. 468-473
CLINICAL PHARMACOKINETICS OF THE ANTIPURINE ANTIFOLATE (6R)-5,10-DIDEAZA-5,6,7,8-TETRAHYDROFOLIC ACID (LOMETREXOL) ADMINISTERED WITH AN ORAL FOLIC-ACID SUPPLEMENT
Authors: WEDGE SR LAOHAVINIJ S TAYLOR GA BODDY A CALVERT AH NEWELL DR
Citation: Sr. Wedge et al., CLINICAL PHARMACOKINETICS OF THE ANTIPURINE ANTIFOLATE (6R)-5,10-DIDEAZA-5,6,7,8-TETRAHYDROFOLIC ACID (LOMETREXOL) ADMINISTERED WITH AN ORAL FOLIC-ACID SUPPLEMENT, Clinical cancer research, 1(12), 1995, pp. 1479-1486
CLINICAL PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES WITH THE NONCLASSICAL ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR AMINO-6-METHYL-4-OXO-5-(4-PYRIDPLTHIO)-QUINAZOLONE DIHYDROCHLORIDE (AG337) GIVEN BY 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION
Authors: RAFI I TAYLOR GA CALVETE JA BODDY AV BALMANNO K BAILEY N LIND M CALVERT AH WEBBER S JACKSON RC JOHNSTON A CLENDENINN N NEWELL DR
Citation: I. Rafi et al., CLINICAL PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES WITH THE NONCLASSICAL ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR AMINO-6-METHYL-4-OXO-5-(4-PYRIDPLTHIO)-QUINAZOLONE DIHYDROCHLORIDE (AG337) GIVEN BY 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION, Clinical cancer research, 1(11), 1995, pp. 1275-1284
PHASE-I AND PHARMACOKINETIC STUDY OF A WATER-SOLUBLE ETOPOSIDE PRODRUG, ETOPOSIDE PHOSPHATE (BMY-40481)
Authors: MILLWARD MJ NEWELL DR MUMMANENI V IGWEMEZIE LN BALMANNO K CHARLTON CJ GUMBRELL L LIND MJ CHAPMAN F PROCTOR M SIMMONDS D CANTWELL BMJ TAYLOR GA MCDANIEL C WINOGRAD B KAUL S BARBAIYA RH CALVERT AH
Citation: Mj. Millward et al., PHASE-I AND PHARMACOKINETIC STUDY OF A WATER-SOLUBLE ETOPOSIDE PRODRUG, ETOPOSIDE PHOSPHATE (BMY-40481), European journal of cancer, 31A(13-14), 1995, pp. 2409-2411
FOLATE-BASED THYMIDYLATE SYNTHASE INHIBITORS AS ANTICANCER DRUGS
Authors: JACKMAN AL CALVERT AH
Citation: Al. Jackman et Ah. Calvert, FOLATE-BASED THYMIDYLATE SYNTHASE INHIBITORS AS ANTICANCER DRUGS, Annals of oncology, 6(9), 1995, pp. 871-881
CANCER-RESEARCH CAMPAIGN PHASE-II TRIAL OF TEMOZOLOMIDE IN METASTATICMELANOMA
Authors: BLEEHEN NM NEWLANDS ES LEE SM THATCHER N SELBY P CALVERT AH RUSTIN GJS BRAMPTON M STEVENS MFG
Citation: Nm. Bleehen et al., CANCER-RESEARCH CAMPAIGN PHASE-II TRIAL OF TEMOZOLOMIDE IN METASTATICMELANOMA, Journal of clinical oncology, 13(4), 1995, pp. 910-913
PHARMACOKINETICS AND PHARMACODYNAMICS OF PROLONGED ORAL ETOPOSIDE IN WOMEN WITH METASTATIC BREAST-CANCER
Authors: MILLWARD MJ NEWELL DR YUEN K MATTHEWS JP BALMANNO K CHARLTON CJ GUMBRELL L LIND MJ CHAPMAN F PROCTOR M SIMMONDS D CANTWELL BMJ CALVERT AH
Citation: Mj. Millward et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF PROLONGED ORAL ETOPOSIDE IN WOMEN WITH METASTATIC BREAST-CANCER, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 161-167
THE ROLE OF INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE AS RESISTANCE-MODIFYING AGENTS IN CANCER-THERAPY
Authors: GRAFFIN RJ CURTIN NJ NEWELL DR GOLDING BT DURKACZ BW CALVERT AH
Citation: Rj. Graffin et al., THE ROLE OF INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE AS RESISTANCE-MODIFYING AGENTS IN CANCER-THERAPY, Biochimie, 77(6), 1995, pp. 408-422
NOVEL POTENT INHIBITORS OF THE DNA-REPAIR ENZYME POLY(ADP-RIBOSE)POLYMERASE (PARP)
Authors: GRIFFIN RJ PEMBERTON LC RHODES D BLEASDALE C BOWMAN K CALVERT AH CURTIN NJ DURKACZ BW NEWELL DR PORTEOUS JK GOLDING BT
Citation: Rj. Griffin et al., NOVEL POTENT INHIBITORS OF THE DNA-REPAIR ENZYME POLY(ADP-RIBOSE)POLYMERASE (PARP), Anti-cancer drug design, 10(6), 1995, pp. 507-514
THE ACTIVITY OF PACLITAXEL IN GASTROINTESTINAL TUMORS - DISCUSSION
Authors: RAGHAVAN D VOKES EE CALVERT AH AISNER J ALBERTS DS GLANTZ MJ",GIANNI,GELMON,SEIDMAN,"ROTH BJ
Citation: D. Raghavan et al., THE ACTIVITY OF PACLITAXEL IN GASTROINTESTINAL TUMORS - DISCUSSION, Seminars in oncology, 22(5), 1995, pp. 51-53
CARBOPLATIN IN COMBINATION WITH PACLITAXEL IN ADVANCED OVARIAN-CANCER- DOSE DETERMINATION AND PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS
Authors: CALVERT AH BODDY A BAILEY NP SIDDIQUI N HUMPHREYS A HUGHES A ROBSON L GUMBRELL L THOMAS H CHAPMAN F PROCTOR M SIMMONS D OAKEY A LIND MJ SINHA DV NEWELL DR
Citation: Ah. Calvert et al., CARBOPLATIN IN COMBINATION WITH PACLITAXEL IN ADVANCED OVARIAN-CANCER- DOSE DETERMINATION AND PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS, Seminars in oncology, 22(5), 1995, pp. 91-98
QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITORS - REPLACEMENT OF GLUTAMIC-ACID IN THE C2-METHYL SERIES
Authors: MARSHAM PR JACKMAN AL BARKER AJ BOYLE FT PEGG SJ WARDLEWORTH JM KIMBELL R OCONNOR BM CALVERT AH HUGHES LR
Citation: Pr. Marsham et al., QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITORS - REPLACEMENT OF GLUTAMIC-ACID IN THE C2-METHYL SERIES, Journal of medicinal chemistry, 38(6), 1995, pp. 994-1004
PACLITAXEL (TAXOL) IN RELAPSED AND REFRACTORY OVARIAN-CANCER - THE UKAND EIRE EXPERIENCE
Authors: GORE ME LEVY V RUSTIN G PERREN T CALVERT AH EARL H THOMPSON JM
Citation: Me. Gore et al., PACLITAXEL (TAXOL) IN RELAPSED AND REFRACTORY OVARIAN-CANCER - THE UKAND EIRE EXPERIENCE, British Journal of Cancer, 72(4), 1995, pp. 1016-1019
MOLECULAR CHARACTERIZATION OF 2 CELL-LINES SELECTED FOR RESISTANCE TOTHE FOLATE-BASED THYMIDYLATE SYNTHASE INHIBITOR, ZD1694
Authors: FREEMANTLE SJ JACKMAN AL KELLAND LR CALVERT AH LUNEC J
Citation: Sj. Freemantle et al., MOLECULAR CHARACTERIZATION OF 2 CELL-LINES SELECTED FOR RESISTANCE TOTHE FOLATE-BASED THYMIDYLATE SYNTHASE INHIBITOR, ZD1694, British Journal of Cancer, 71(5), 1995, pp. 925-930
THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR TO DELIVER 4 CYCLES OF IFOSFAMIDE AND EPIRUBICIN EVERY 14 DAYS IN WOMEN WITH ADVANCED OR METASTATIC BREAST-CANCER
Authors: LIND MJ GUMBRELL L CANTWELL BMJ MILLWARD MJ SIMMONDS D PROCTOR M CHAPMAN F MCCANN E MIDDLETON I CALVERT AH
Citation: Mj. Lind et al., THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR TO DELIVER 4 CYCLES OF IFOSFAMIDE AND EPIRUBICIN EVERY 14 DAYS IN WOMEN WITH ADVANCED OR METASTATIC BREAST-CANCER, British Journal of Cancer, 71(3), 1995, pp. 610-613
A DOSE-FINDING STUDY OF GRANISETRON, A NOVEL ANTIEMETIC, IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN
Authors: GOEDHALS L JORDAAN JP KAYE SB ARMAND JP VEENHOF CHN FALKSON G SOUKOP M SCHNEIDER M OBERLING F BUI BN ROCHE H ADENIS L CATY A BLIJHAM GH DEWEWEIRE A COIFFIER B SOTTO JJ VANHEUKELOM LS TAGNON A SLEE PHTJ KROEKS MVAM RAVEZ P CUPISSOL D KEIZER HJ BRUNNER K CALVERT AH YERNAULT JC LIBERT P BROHEE D
Citation: L. Goedhals et al., A DOSE-FINDING STUDY OF GRANISETRON, A NOVEL ANTIEMETIC, IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN, Supportive care in cancer, 2(3), 1994, pp. 177-183
PROBING THE ACTIVE-SITE AND MECHANISM OF ACTION OF O-6-METHYLGUANINE-DNA METHYLTRANSFERASE WITH SUBSTRATE-ANALOGS TO (O-6-SUBSTITUTED GUANINES)
Authors: ARRIS CE BLEASDALE C CALVERT AH CURTIN NJ DALBY C GOLDING BT GRIFFIN RJ LUNN JM MAJOR GN NEWELL DR
Citation: Ce. Arris et al., PROBING THE ACTIVE-SITE AND MECHANISM OF ACTION OF O-6-METHYLGUANINE-DNA METHYLTRANSFERASE WITH SUBSTRATE-ANALOGS TO (O-6-SUBSTITUTED GUANINES), Anti-cancer drug design, 9(5), 1994, pp. 401-408
DOSE OPTIMIZATION OF CARBOPLATIN IN ADULTS
Authors: CALVERT AH
Citation: Ah. Calvert, DOSE OPTIMIZATION OF CARBOPLATIN IN ADULTS, Anticancer research, 14(6A), 1994, pp. 2273-2277
CARBOPLATIN AND GRANULOCYTE-COLONY-STIMULATING FACTOR AS FIRST-LINE TREATMENT FOR EPITHELIAL OVARIAN-CANCER - A PHASE-I DOSE-INTENSITY ESCALATION STUDY
Authors: CALVERT AH LIND MJ GHAZALASWAD S GUMBRELL L MILLWARD MJ BAILEY NP DOREGREEN F CHAPMAN F SIMMONS D PROCTOR M OAKEY A SINHA DP MCCANN E MIDDLETON I
Citation: Ah. Calvert et al., CARBOPLATIN AND GRANULOCYTE-COLONY-STIMULATING FACTOR AS FIRST-LINE TREATMENT FOR EPITHELIAL OVARIAN-CANCER - A PHASE-I DOSE-INTENSITY ESCALATION STUDY, Seminars in oncology, 21(5), 1994, pp. 1-6
A STRATEGY FOR THE DESIGN OF MEMBRANE-PERMEABLE FOLYLPOLY-GAMMA-GLUTAMATE SYNTHETASE INHIBITORS - BAY-REGION-SUBSTITUTED 2-DESAMINO-2-METHYL-5,8-DIDEAZAFOLATE ANALOGS
Authors: SANGHANI PC JACKMAN A EVANS VR THORNTON T HUGHES L CALVERT AH MORAN RG
Citation: Pc. Sanghani et al., A STRATEGY FOR THE DESIGN OF MEMBRANE-PERMEABLE FOLYLPOLY-GAMMA-GLUTAMATE SYNTHETASE INHIBITORS - BAY-REGION-SUBSTITUTED 2-DESAMINO-2-METHYL-5,8-DIDEAZAFOLATE ANALOGS, Molecular pharmacology, 45(2), 1994, pp. 341-351
THE SYNTHESIS AND THYMIDYLATE SYNTHASE INHIBITORY ACTIVITY OF L-GAMMA-L-LINKED DIPEPTIDE AND L-GAMMA-AMIDE ANALOGS OF DESAMINO-2-METHYL-N(10)-PROPARGYL-5,8-DIDEAZAFOLIC ACID (ICI-198583)
Authors: BISSET GMF BAVETSIAS V THORNTON TJ PAWELCZAK K CALVERT AH HUGHES LR JACKMAN AL
Citation: Gmf. Bisset et al., THE SYNTHESIS AND THYMIDYLATE SYNTHASE INHIBITORY ACTIVITY OF L-GAMMA-L-LINKED DIPEPTIDE AND L-GAMMA-AMIDE ANALOGS OF DESAMINO-2-METHYL-N(10)-PROPARGYL-5,8-DIDEAZAFOLIC ACID (ICI-198583), Journal of medicinal chemistry, 37(20), 1994, pp. 3294-3302
A CANCER-RESEARCH CAMPAIGN (CRC) PHASE-II TRIAL OF CB10-277 GIVEN BY 24-HOUR INFUSION FOR MALIGNANT-MELANOMA
Authors: BLEEHEN NM CALVERT AH LEE SM HARPER P KAYE SB JUDSON I BRAMPTON M
Citation: Nm. Bleehen et al., A CANCER-RESEARCH CAMPAIGN (CRC) PHASE-II TRIAL OF CB10-277 GIVEN BY 24-HOUR INFUSION FOR MALIGNANT-MELANOMA, British Journal of Cancer, 70(4), 1994, pp. 775-777
Risultati: 1-25 | 26-50 | 51-53